Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $267.9 million.

  • Integra Lifesciences Holdings' Cash & Current Investments fell 350.85% to $267.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $267.9 million, marking a year-over-year decrease of 350.85%. This contributed to the annual value of $273.6 million for FY2024, which is 1148.55% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Cash & Current Investments of $267.9 million as of Q3 2025, which was down 350.85% from $253.6 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Cash & Current Investments ranged from a high of $663.1 million in Q1 2024 and a low of $253.6 million during Q2 2025
  • In the last 5 years, Integra Lifesciences Holdings' Cash & Current Investments had a median value of $309.2 million in 2023 and averaged $374.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 11573.56% in 2024, then tumbled by 5878.39% in 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Cash & Current Investments (Quarter) stood at $513.4 million in 2021, then decreased by 11.06% to $456.7 million in 2022, then tumbled by 32.31% to $309.1 million in 2023, then decreased by 11.49% to $273.6 million in 2024, then dropped by 2.08% to $267.9 million in 2025.
  • Its Cash & Current Investments was $267.9 million in Q3 2025, compared to $253.6 million in Q2 2025 and $273.3 million in Q1 2025.